GCP2 Antibodies

Santa Cruz Biotechnology delivers a wide array of GCP2 monoclonal antibodies for investigating GCP2 in cellular processes. The monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA) applications.GCP2, or Guanine Cytosine Binding Protein 2, functions as a critical regulator of gene expression and plays a significant role in cellular signaling pathways. GCP2 actively participates in cell proliferation, differentiation, and apoptosis, making it a crucial target for cancer research and studies of other diseases. Understanding GCP2 function can reveal molecular mechanisms underlying various pathological conditions. Research has shown that GCP2 expression levels often correlate with disease progression in several cancer types. Recent studies have highlighted GCP2's potential as a therapeutic target in treating specific cancers. Investigating GCP2's role in different tissue types continues to uncover new insights about its biological significance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of GCP2's role in health and disease.